Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor

Claudia Papi, Giuseppe Granata, Marco Galluzzo, Raffaele Iorio*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

na
Lingua originaleEnglish
pagine (da-a)1105-1107
Numero di pagine3
RivistaNeurological Sciences
Volume44
DOI
Stato di pubblicazionePubblicato - 2023

Keywords

  • Autoantibodies
  • Humans
  • Interleukin Inhibitors
  • Interleukin-17
  • Letter
  • Muscles
  • Myasthenia Gravis
  • antibody
  • antibody blood level
  • antibody detection
  • antibody titer
  • autoantibody
  • case report
  • clinical article
  • cyclosporine
  • drug dose reduction
  • drug tolerability
  • drug withdrawal
  • gastrointestinal symptom
  • human
  • interleukin 17
  • interleukin 17, adult
  • male
  • muscle
  • muscle specific kinase
  • myasthenia gravis
  • myasthenia gravis, Antibodies
  • neurologic examination
  • phosphotransferase
  • prednisone
  • psoriasis vulgaris
  • pyridostigmine
  • secukinumab
  • single fiber electromyography
  • steroid therapy
  • treatment interruption
  • unclassified drug

Fingerprint

Entra nei temi di ricerca di 'Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor'. Insieme formano una fingerprint unica.

Cita questo